Virologist: UK-approved Oxford/AstraZeneca vaccine is a ‘ray of hope’

Virologist: UK-approved Oxford/AstraZeneca vaccine is a ‘ray of hope’ 1


UK regulators have approved the use of the Oxford University/AstraZeneca coronavirus vaccine, which is cheaper and easier to distribute than some alternatives and could in time offer a route out of the pandemic for large parts of the world. CNN’s Isa Soares speaks with Lawrence Young, a virologist and professor of molecular oncology at the University of Warwick. #CNN #News

44 Comments on "Virologist: UK-approved Oxford/AstraZeneca vaccine is a ‘ray of hope’"

  1. CHING CHONG JOE | December 30, 2020 at 9:27 AM | Reply

    After January 20th the vaccine will be free in these United States.

  2. Hello my friend! What do you think about this video? I think it’s good for hope me.

  3. It’s the guy from Nathan for you the resemblance is uncanny

  4. UK just did a ”post-brexit” deal and like a week later a vaccine comes available. How convenient.

  5. Create as many vaccines as possible. I won’t complain

  6. Why don’t we wait a month then make an actual conclusion? Anything before that is a hypothesis……

    • Biden’s
      Freudian slip [ˌfroidēən ˈslip] noun TRUTHISMS FLYING OUT OF HIS CORRUPT PIE HOLE.
      Freudian slips (plural noun)an unintentional error regarded as revealing subconscious feelings.
      According to psychoanalytic thought, you can trace these slip-ups back to unconscious desires and urges, whether those are:

      1) things you actually want to say but feel unable to express
      2) unrealized feelings that haven’t yet entered your realm of conscious thought
      3) Freudian slips are incredibly common. But do they really always relate to secret impulses and unexpressed desires, or is there a simpler explanation?

  7. annoyed aussie | December 30, 2020 at 3:28 PM | Reply

    This one is the game changer already in production in about 5 countries with a low profit margin and easy to transport.

  8. Astrazeneca is the best to do it.

  9. The British – their conservatives included – haven’t got as batchit crazy as Americans (mostly Republicans).

  10. Belgium, China, Russia, UK vaccines.
    US warp speed?

  11. Good now we all can go to Washington to party Jan 6 be there.

  12. Mobbdeepak McMacaveli Shakoor | December 30, 2020 at 6:28 PM | Reply

    Seroquel Scandals
    Early on, the company had a history of playing it safe. In the 1970s, Astra saw the future of antidepressants. It developed the first selective serotonin reuptake inhibitor (SSRI) called zimelidine, and began selling it 1982. But the drug produced a rare side effect that could damage the nervous system, and the company recalled it a year later. By recalling zimelidine, it avoided potential catastrophic losses from possible lawsuits.

    But it had already received harsh criticism for its involvement in scandals for its blockbuster antipsychotics, Seroquel and Seroquel XR. Critics say the company was more focused on maximizing profits while it still had the patent on the drug than on patient and trial participant safety.

    In addition to paying $350 million to resolve more than 23,000 lawsuits that allege Seroquel can cause diabetes, the company paid to settle illegal marketing charges. It also faced a number of scandals including corrupt data in studies for marketing the drug to children, a sex scandal and a poorly run clinical trial that could have compromised patient safety and data reliability.

    Marketing Seroquel for Children
    Dr. Melissa DelBello was the lead author of a ground-breaking 2002 study that found AstraZeneca’s atypical antipsychotic Seroquel (quetiapine) was safe for use in children. AstraZeneca financed the study which included 30 children diagnosed with bipolar disorder. In the end, only eight children taking Seroquel completed the trial, and DelBello determined the study was inconclusive.

    However, the study was published anyway and concluded Seroquel was more effective in children than a test group not receiving the drug. The publication led to a national recommendation that atypical antipsychotics be the leading choice for children with bipolar disorder.

    AstraZeneca covered up study results that revealed Seroquel was either inconclusive or harmful.
    Other studies involving Seroquel produced inconclusive or harmful results. Those were never published. It was later revealed that AstraZeneca systematically covered up the results. A company email used as evidence in a court case revealed: “Thus far, we have buried trials 15, 31, 56. The larger issue is how do we face the outside world when they begin to criticize us for suppressing data.”

    In 2002, U.S. Sen. Charles Grassley criticized DelBello for receiving at least $238,000 in consulting fees and travel costs from AstraZeneca.

    After years of investigations, AstraZeneca paid a $520 million fine brought by the U.S. Department of Justice for promoting Seroquel for unapproved uses. The company also paid $647 million to settle global lawsuits for failing to warn the public of Seroquel’s side effects.

    ‘Sex-for-Studies’ Seroquel Scandal
    In 2009, a Florida lawsuit claimed then U.S. medical director for Seroquel Dr. Wayne MacFadden had sexual relationships with a clinical researcher who wrote journal articles favorable to Seroquel and a medical marketer who promoted Seroquel. The case was one of 9,000 claiming people developed diabetes and gained weight while on the drug.

    Plaintiffs said these relationships were improper because research was supposed to be independent of AstraZeneca. MacFadden also had sexual relationships with employees of competitors and asked for trade secrets, CBS News and MedPage Today reported.

    “The mere existence of these relationships calls into question the integrity of the scientific work product of those involved,” according to documents written by plaintiffs’ attorneys in 2009.

    E-mails also surfaced showing AstraZeneca’s publications manager John Tumas buried three clinical trials with unfavorable Seroquel clinical data.

    Poorly Organized Clinical Trial
    In 2014, a Seroquel XR trial for borderline personality disorder headed by Dr. S. Charles Schultz faced scrutiny because of poor oversight, the New York Times reported. AstraZeneca paid Schultz, the head of the department of psychiatry at the University of Minnesota, to conduct the trial. In addition, he received more than $112,000 for “speaking and consulting fees and other payments” from 2002 to 2007.

    Because of lack of supervision, two participants at a facility for sex offenders were able to fake their way into the trial. One of these men slipped Seroquel XR to unsuspecting staff and residents. The men were removed from the trial, but no one followed up with an investigation.

    Following the Seroquel XR trial debacle, Schultz stepped down as head of psychiatry at the university.

    Despite the sloppy trial and about one third of the participants dropping out because of side effects, results published in the American Journal of Psychiatry showed the drug as a promising treatment for borderline personality disorder. AstraZeneca didn’t pursue formal approval from the FDA, however.

    Prior to this trial, the University of Minnesota ran a Seroquel trial in 2004, and one participant, Dan Markingson, committed suicide while on the drug.

    AstraZeneca’s Drug Side Effect Litigation
    In addition to AstraZeneca’s antipsychotic controversy, it also faced growing legal problems from some of its blockbuster medications. People who took some of the company’s best-selling drugs say the drugmaker failed to warn of side effects.

    Crestor 10mg Pills
    Crestor 10mg pill
    The cholesterol drug Crestor (rosuvastatin) is used to prevent or treat heart disease, heart attacks and strokes.

    People harmed by Crestor took AstraZeneca to court, claiming in lawsuits the drug contained dangerous defects. A consumer advocacy group also called for the recall of Crestor from the U.S. market but no recall was ordered.

    Onglyza & Kombiglyze XR
    Onglyza 5mg Pills
    Onglyza 5mg pill
    The FDA approved Onglyza (saxagliptin) in 2009 to treat Type 2 diabetes. AstraZeneca and partner Bristol-Myers Squibb made hundreds of millions of dollars annually from Onglyza, but a study reported Onglyza increased the risk of hospitalizations due to heart failure. The FDA warned of the increased risk in April 2015.

    A month later, a woman claimed her mother died from heart failure caused by Onglyza and filed a lawsuit against AstraZeneca. Now more lawsuits are mounting for Onglyza and heart failure.

    Farxiga 10mg pill
    Farxiga 10mg pill
    The FDA rejected Bristol-Myers and AstraZeneca’s once-daily Farxiga (dapagliflozin) before approving it in 2014. The FDA had originally denied it because data in studies showed a possible risk of bladder cancer.

    After the FDA released several warnings linking the drug to serious side effects, numerous law firms are analyzing cases from people who suffered from ketoacidosis, kidney problems, UTIs or other conditions possibly caused by Farxiga.

  13. We’re getting the vaccine in batches the 2nd isn’t till the end of February, they forget weather like snow can play a part in slowing the vaccination process down. I don’t believe Matt when he said “we can be out of this by spring.”

  14. Arsenal Forever ! | December 30, 2020 at 7:23 PM | Reply

    Let’s hope Delboy & Rodney aren’t delivering these

  15. Question: Were all study participants required to wear masks as those in other covid-19 vaccine trials?
    Were study participants exposed to the virus?

  16. The UK is using logic. The US has turned the vaccine into a political football. People will die and the politicians are MURDERERS.

  17. Get that thing multiplied and out there dammit !



  20. You can trust him — he’s got lots o’ books behind him…. 😂 🤣 😂 🤣 😂 🤣 😂 🤣

Leave a comment

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.